They will develop and validate new peripheral nerve substitutes created using advanced biofabrication techniques, such as 3D printing and the use of biological matrices.
Read more
The Sant Pau Research Institute (IR Sant Pau) is leading the new multicenter clinical trial FTAA (Fast Track in Acute Appendicitis), aimed at improving the postoperative management of complicated appe...
Read more
Según este subestudio, centrado en el reinfarto, del ensayo MOSCA-FRAIL, la estrategia invasiva no demostró prevenir un nuevo infarto en pacientes frágiles
Read more
The study will evaluate the safety and efficacy of the molecule IMP1734, a selective inhibitor that blocks a key enzyme for DNA repair in cancer cells.
Read more
Concluyen que aunque no existen diferencias significativas en el número de pacientes que mejoraron el daño pulmonar provocado por un síndrome de dificultad respiratoria aguda inducido por Covid-19 ...
Read more
It has been today announced that they has received “Decision to grant” communications from the Canadian Intellectual Property Office and the Israel Patent Office for its patent applications CA3071...
Read more
Nurses Nuria Sánchez and Paula Calvo, from the Clinical Trials Unit of the Marqués de Valdecilla University Hospital (HUMV/IDIVAL), have participated in an international study conducted within the f...
Read more
The financial services company Inveready, a member of Catalonia.health, announces the successful closure of its life sciences fund Inveready Innvierte Biotech II. This is the second fund the firm has ...
Read more
Highlight Therapeutics and CNIO are collaborating to proof BO-112 effectiveness against the most common form of skin cancer, which is linked to sun exposure and is on the rise.
Read more
The study, published in the journal Bioorganic Chemistry, identifies molecules capable of blocking a key interaction in the progression of this type of tumor.
Read more
Treatment with durvalumab, a PD-L1 inhibitor monoclonal antibody, has become established recently as the standard therapy for patients with unresectable stage III non-small cell lung cancer (NSCLC) wh...
Read more
The BOHEMIA trial, the largest study on ivermectin for malaria to date, showed a 26% reduction in new malaria infection on top of existing bed nets, providing strong evidence of ivermectin’s potenti...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
